Following the frequent suspicions regarding the safety of cholesterol-lowering drugs in the pre-statin era,1 statins have been a recurrent object of various concerns and alarming news. For example, ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Learn everything you need to know about Vanguard Value ETF (VTV) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the right fund ...

Learn everything you need to know about iShares Core S&P US Value ETF (IUSV) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the ...

If your company is considering selling products under its name or adding new products to its current lineup, private labeling may be a good option for you. Private labeling allows you to outsource the ...

The Magnificent Seven represent 34.3% of the S&P 500 as of February 2026, up from 12.5% in 2016. From 2016 through 2025, these seven companies achieved an 875.5% return, outperforming the S&P 500. The ...